For its fourth fiscal quarter (ending December 31), ProPhase Labs Inc (NASDAQ: PRPH) has reported E.P.S. of $-0.48 compared to $-0.16 a year ago. For the latest four quarters through December 31, E.P.S. were $-0.98 versus $1.17 for the same period a year ago.
Recent Price Action
ProPhase Labs Inc (NASDAQ: PRPH) stock enjoyed a large increase of 3.7% on 3/15/24. The stock closed at $5.04. Moreover, this advance was accompanied by above average trading volume at 121% of normal. The stock has been weak relative to the market over the last nine months but has risen 6.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, PRPH is expected to be a modest Value Eraser.
ProPhase Labs has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. ProPhase Labs has a slightly negative Power Rating of 32 and a poor Appreciation Score of 29, producing the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment